Metabolism of vitamin D3-3H in human subjects: distribution in blood, bile, feces, and urine

The Journal of Clinical Investigation
L V AvioliH F DeLuca

Abstract

Vitamin D(3)-(3)H has been administered intravenously to seven normal subjects, three patients with biliary fistulas, and four patients with cirrhosis. Plasma D(3)-(3)H half-times normally ranged from 20 to 30 hours. in vivo evidence that a metabolic transformation of vitamin D occurs was obtained, and a polar biologically active vitamin D metabolite was isolated from plasma. Urinary radioactivity averaged 2.4% of the administered dose for the 48-hour period after infusion, and all the excreted radioactivity represented chemically altered metabolites of vitamin D. The metabolites in urine were mainly water-soluble, with 26% in conjugated form. From 3 to 6% of the injected radioactivity was excreted in the bile of subjects with T-tube drainage and 5% in the feces of patients having no T-tube. The pattern of fecal and biliary radioactivity suggested that the passage of vitamin D and its metabolites from bile into the intestine represents an essential stage for the fecal excretion of vitamin D metabolites in man. Abnormally slow plasma disappearance of vitamin D(3)-(3)H in patients with cirrhosis was associated with a significant decrease in the quantity and rate of glucuronide metabolite excretion in the urine.

References

Jan 1, 1966·The Journal of Clinical Investigation·G R ThompsonC C Booth
Oct 1, 1965·Archives of Biochemistry and Biophysics·P S Chen, K Lane
Aug 24, 1966·Biochimica Et Biophysica Acta·P P Nair, C Bucana
Feb 15, 1966·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·R K CallowG A Thompson
Sep 1, 1956·The Journal of Clinical Investigation·H L BRADLOWL HELLMAN
Dec 1, 1956·The Journal of Clinical Investigation·A A SANDBERG, W R SLAUNWHITE
Aug 1, 1959·Canadian Journal of Biochemistry and Physiology·E G BLIGH, W J DYER
May 1, 1964·The Journal of Clinical Investigation·D SCHACHTERS KOWARSKI
Jul 1, 1964·Archives of Biochemistry and Biophysics·A W NORMAN, H F DELUCA
Oct 1, 1964·Archives of Biochemistry and Biophysics·A W NORMANH F DELUCA
Feb 1, 1960·The Journal of Clinical Investigation·R E PETERSON

❮ Previous
Next ❯

Citations

Apr 1, 1986·Digestive Diseases and Sciences·J E LedgerJ E Compston
Mar 1, 1981·Digestive Diseases and Sciences·R KumarJ M Londowski
Feb 1, 1971·The American Journal of Digestive Diseases·D HollanderW Volwiler
Jan 1, 1980·Journal of Steroid Biochemistry·C H ShackletonJ Whitney
Feb 1, 1985·Journal of Steroid Biochemistry·R BoschS A Duursma
Jun 1, 1987·Journal of Steroid Biochemistry·B Ayton, F Martin
Jul 1, 1973·Journal of the Neurological Sciences·K VarkeyG M Taori
Apr 30, 1983·Lancet·D R Fraser
Sep 1, 1984·Lancet·J Compston, J E Ledger
Mar 1, 1980·Clinics in Endocrinology and Metabolism·E B Mawer
Jun 19, 1969·The New England Journal of Medicine·D V Kimberg
Jan 1, 1973·Archives of Disease in Childhood·T C Stamp
Oct 10, 1970·British Medical Journal·A Richens, D J Rowe
Apr 1, 1978·Gut·R T JungD E Lawson
Dec 1, 1967·The Journal of Clinical Investigation·L V AvioliH F DeLuca
Oct 1, 1968·The Journal of Clinical Investigation·L V AvioliE Slatopolsky
Jul 1, 1969·The Journal of Clinical Investigation·G Ponchon, H F DeLuca
Nov 1, 1969·The Journal of Clinical Investigation·G PonchonH F DeLuca
Apr 1, 1972·The Journal of Clinical Investigation·T J HahnL V Avioli
Feb 1, 1980·The Journal of Clinical Investigation·R KumarJ M Londowski
Dec 1, 1980·The Journal of Clinical Investigation·S NagubandiP S Tietz
Jun 1, 1993·The Journal of Clinical Investigation·J G HaddadJ Wortsman
Feb 23, 2011·European Journal of Endocrinology·Edo AartsHans de Boer
Jan 22, 2011·Journal of Perinatology : Official Journal of the California Perinatal Association·D E Roth
Sep 12, 2013·Current Medical Research and Opinion·Maria Luisa Brandi, Salvatore Minisola
Nov 1, 1972·Kidney International·L V Avioli
Aug 1, 1988·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·V PlourdeP M Huet
Nov 1, 1979·Clinics in Endocrinology and Metabolism·L V Avioli
Mar 1, 1980·Clinics in Endocrinology and Metabolism·S C Meredith, I H Rosenberg
Jul 1, 1992·Clinical Endocrinology·M R ClementsP H Adams
Nov 1, 1979·Clinical Endocrinology·J M BarragryR D Cohen
Sep 1, 1969·Biochemistry·T SudaJ W Blunt
May 8, 2001·Journal of Gastroenterology and Hepatology·I G FinlayD L Morris

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.